taxifolin and 9,10-dimethyl-1,2-benzanthracene

taxifolin has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bose, P; Haque, MW; Lapenna, A; Pattanayak, SP; Siddique, MUM; Sunita, P	1

Other Studies

1 other study(ies) available for taxifolin and 9,10-dimethyl-1,2-benzanthracene

Article	Year
Taxifolin binds with LXR (α & β) to attenuate DMBA-induced mammary carcinogenesis through mTOR/Maf-1/PTEN pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 105 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Female; Liver X Receptors; MafB Transcription Factor; Mammary Neoplasms, Experimental; Molecular Docking Simulation; Oncogene Proteins; Protein Binding; PTEN Phosphohydrolase; Quercetin; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases	2018

Article

Year

Taxifolin binds with LXR (α & β) to attenuate DMBA-induced mammary carcinogenesis through mTOR/Maf-1/PTEN pathway.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 105

Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Female; Liver X Receptors; MafB Transcription Factor; Mammary Neoplasms, Experimental; Molecular Docking Simulation; Oncogene Proteins; Protein Binding; PTEN Phosphohydrolase; Quercetin; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases

2018